D & K Healthcare Resources Has Recalled Zyprexa Tablets

[Wendy]

(SafetyAlerts) - The FDA has released the following information.

PRODUCT
a) Zyprexa Tablets (Olanzapine), 5 mg., 60-tablet bottles,
Rx only, Eli Lilly and Company, Indianapolis, IN.
Recall # D-338-3;
b) Zyprexa Tablets (Olanzapine), 10 mg., 60-tablet bottles,
Rx only, NDC 0002-4117-60, Eli Lilly and Company,
Indianapolis, IN. Recall # D-339-3;
c) Zyprexa Tablets (Olanzapine), 15 mg., 60-tablet bottles,
Rx only, NDC-0002-4115-60, Eli Lilly and Company,
Indianapolis, IN. Recall # D-340-3;
d) Zyprexa Tablets (Olanzapine) 20 mg., 60-tablet bottles,
Rx only, Eli Lilly and Company, Indianapolis, IN.
Recall # D-341-3.

CODE
a) Lot Number 6AA66A;
b) Lot numbers 6AH19A, 7AA39A,and 7EA97A;
c) Lot Numbers 6AH35A, 6AG70A, 7AA77A, 7ED06A, 7ED00A, and
7EA53A;
d) Lot Numbers 7AA79A, 7EC85A, 7EA19A, and 7EA22A.

RECALLING FIRM
D & K Healthcare Resources, Inc., Saint Louis, MO, by e-mail on August 25, 2003.
MANUFACTURER-UNKNOWN. Firm initiated recall is ongoing.

REASON
Counterfeit: An unknown number of bottles bearing these lot numbers are counterfeit, in that they have been repackaged, relabeled and/or may contain different strengths or mixed strength tablets differing from their labeled contents and/or bear extended expiration dates, as the source of the repacked and/or relabeled bottles is unknown.

VOLUME OF PRODUCT IN COMMERCE
31,553/60-tablet bottles.

DISTRIBUTION
Nationwide.